Sciencepulse

Superbugs Are Gaining Ground, and the Treatment Gap Is Widening

Health·October 26, 2026

Superbugs Are Gaining Ground, and the Treatment Gap Is Widening

Antibiotic resistance is no longer a distant warning. According to the opening episode of a three-part series on superbugs, drug-resistant bacteria are already killing people, and the problem is expected to grow sharply in the years ahead. Reporter Roland Pease sets out to explain how the situation reached this point.

The story starts with penicillin. When the discovery was turned into a usable drug in the 1940s, it transformed medicine, making infections that once killed easily treatable. Bacteria adapt, however. Resistant strains began to appear soon after antibiotics came into wide use, and each new drug has tended to be followed by microbes that find a way around it. The episode follows that back-and-forth from the early decades of antibiotics to the present day.

The human consequences sit at the centre of the programme. When an infection stops responding to standard treatment, patients can face longer hospital stays, intensive care, and surgery that carries greater risk. In the worst cases, the infection is fatal. Routine procedures that depend on antibiotics to prevent infection, from caesarean sections to cancer treatment, become harder to carry out safely once those drugs lose their power.

The series also focuses on what is becoming a widening treatment gap, the space between the infections doctors can still cure and those they cannot. Bacteria are evolving faster than new antibiotics are reaching patients, and the development of new drugs has been widely reported as slow for decades. That leaves clinicians with fewer options just as resistance spreads.

This first instalment lays out the history and the current toll. The remaining two parts will carry the story forward.

Reporting based on an external source.